Chair of the Science, Medicine and Development Council
Michael joined the Ferring Board of Directors in July 2024 as Chairman of the Research and Development and Production Committee, with responsibility for ensuring the patient-centric focus of Ferring’s product development strategy. This committee ceased to exist in September 2025, and in October he became Chairman of the Science, Medicine and Development Council. He was formerly Chief Medical Officer at Merck & Co., Inc, a Professor of Medicine at Harvard Medical School, and Dean of Tufts University School of Medicine. Before joining Ferring, Michael was Chief Medical Officer of the life sciences venture firm Flagship Pioneering, and served as Director of several of its portfolio companies. During his career, he has also held leadership roles in academic medicine and scientific and management roles at a number of biopharmaceutical companies. Michael gained his M.D. magna cum laude degree from Harvard University in the USA. He was recently elected to the Board of Overseers of Harvard University, one of the university’s governing bodies.
